344
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Individual consent in cluster randomised trials for non-pharmaceutical interventions: going beyond the Ottawa statement

, ORCID Icon, , ORCID Icon &
Pages 1-9 | Received 30 Sep 2023, Accepted 27 Mar 2024, Published online: 18 Apr 2024

References

  • Abdin, Y. A., de Pretis, F., & Landes, J. (2023, 20). Fast methods for drug approval: Research perspectives for pandemic preparedness. International Journal of Environmental Research and Public Health, 20(3), 2404. https://doi.org/10.3390/ijerph20032404
  • Almeida, M., Challa, M., Ribeiro, M., Harrison, A. M., & Castro, M. C. (2022). Editorial perspective: The mental health impact of school closures during the COVID‐19 pandemic. Journal of Child Psychology and Psychiatry, 63(5), 608–612. https://doi.org/10.1111/jcpp.13535
  • Aronson, J. K., Auker‐Howlett, D., Ghiara, V., Kelly, M. P., & Williamson, J. (2021). The use of mechanistic reasoning in assessing coronavirus interventions. Journal of Evaluation in Clinical Practice, 27(3), 684–693. https://doi.org/10.1111/jep.13438
  • Aronson, J. K., La Caze, A., Kelly, M. P., Parkkinen, V.-P., & Williamson, J. (2018). The use of mechanistic evidence in drug approval. Journal of Evaluation in Clinical Practice, 24(5), 1166–1176. https://doi.org/10.1111/jep.12960
  • Bédécarrats F., Guérin,I., Roubaud,F. (2020). Editors’ Introduction: Controversies around RCT in Development: Epistemology, Ethics, and Politics. In F. Bédécarrats, I. Guérin & F. Roubaud (Eds.), Randomized control trials in the field of development: A critical perspective. Oxford University Press. Retrieved 22 March. from https://doi.org/10.1093/oso/9780198865360.003.0001
  • Bjørnson Hagen, H. (2022). Ber Kjerkhol vurdere unntak i loven for å forske på pandemien, Khrono. https://www.khrono.no/ber-kjerkhol-vurdere-unntak-i-loven-for-a-forske-pa-pandemien/652267
  • Cartwright, N. (2012). Presidential address: Will this policy work for you? Predicting effectiveness better: How philosophy helps. Philosophy of Science, 79(5), 973–989. https://doi.org/10.1086/668041
  • Fretheim, A., Flatø, M., Steens, A., Flottorp, S. A., Rose, C. J., Telle, K. E., Kinge, J. M., & Schwarze, P. E. (2020). COVID-19: We need randomised trials of school closures. Journal of Epidemiology and Community Health, 74(12), 1078–1079. https://doi.org/10.1136/jech-2020-214262
  • Greenhalgh, T., Fisman, D., Cane, D. J., Oliver, M., & Macintyre, C. R. (2022). Adapt or die: How the pandemic made the shift from EBM to EBM+ more urgent. BMJ Evidence-Based Medicine, 27(5), 253–260. https://doi.org/10.1136/bmjebm-2022-111952
  • Gulliford, M. C., Adams, G., Ukoumunne, O. C., Latinovic, R., Chinn, S., & Campbell, M. J. (2005). Intraclass correlation coefficient and outcome prevalence are associated in clustered binary data. Journal of Clinical Epidemiology, 58(3), 246–251. https://doi.org/10.1016/j.jclinepi.2004.08.012
  • Haber, N. A., Wieten, S. E., Smith, E. R., & Nunan, D. (2021). Much ado about something: A response to “COVID-19: Underpowered randomised trials, or no randomised trials? Trials, 22(1), 780. https://doi.org/10.1186/s13063-021-05755-y
  • Hammerstein, S., König, C., Dreisörner, T., & Frey, A. (2021). Effects of COVID-19-related school closures on student achievement-a systematic review. Frontiers in Psychology, 12, 12. https://doi.org/10.3389/fpsyg.2021.746289
  • Health Research Act. (2009). 5 §19. https://lovdata.no/dokument/NL/lov/2008-06-20-44
  • Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., Chen, G., Olivier, K. N., Ghio, A., Tse, L. V., Leist, S. R., Gralinski, L. E., Schäfer, A., Dang, H., Gilmore, R., &, and Baric, R. S. (2020). SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell, 182(2), 429–446.e14. https://doi.org/10.1016/j.cell.2020.05.042
  • Howick, J. (2011). The philosophy of evidence-based medicine. Wiley-Blackwell, BMJ Books.
  • Kamineni, M., Engø-Monsen, K., Midtbø, J. E., Forland, F., de Blasio, B. F., Frigessi, A., & Engebretsen, S. (2023). Effects of non-compulsory and mandatory COVID-19 interventions on travel distance and time away from home, Norway, 2021. Eurosurveillance, 28(17). https://doi.org/10.2807/1560-7917.ES.2023.28.17.2200382
  • Leclerc, Q. J., Fuller, N. M., Knight, L. E., Funk, S., & Knight, G. M. (2020). What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome Open Research, 5, 83. https://doi.org/10.12688/wellcomeopenres.15889.2
  • Lorig, F., Johansson, E., & Davidsson, P. (2021). Agent-based social simulation of the covid-19 pandemic: A systematic review. Journal of Artificial Societies and Social Simulation, 3(24). https://doi.org/10.18564/jasss.4601
  • Maziarz, M., & Stencel, A. (2022). The failure of drug repurposing for COVID‑19 as an effect of excessive hypothesis testing and weak mechanistic evidence. History and Philosophy of the Life Sciences, 44(4), 47. https://doi.org/10.1007/s40656-022-00532-9
  • Norwegian Institute of Public Health. (2020). Helseforskningsloven og forskning på smitteverntiltak [The health research act and research on infection control measures]. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.khrono.no/files/2022/01/12/Brev%20til%20HOD%20og%20KD%20fra%20styringsgruppen%20i%20kunnskapsprogrammet.pdf
  • Norwegian Institute of Public Health. (2021). Norwegian Science Program on COVID-19. https://www.fhi.no/en/id/corona/norwegian-science-programme-on-covid19/about-the-programme/
  • Norwegian National Research Ethics Committees. (2020). Prosjektåpning under pandemien - evaluering. [Project opening during the pandemics – evaluation]. https://www.forskningsetikk.no/om-oss/komiteer-og-utvalg/nem/sok-i-nems-vedtak/prosjektapning-under-pandemien—evaluering-sape/
  • Norwegian National Research Ethics Committees. (2021). Lovtolkning, pandemi og genetikk skapte engasjement. [Legal interpretation, pandemic, and genetics sparked engagement] https://www.forskningsetikk.no/aktuelt/lovtolkning-pandemi-og-genetikk-skapte-engasjement/#b1
  • Parkkinen, V.-P., Wallmann, C., Wilde, M., Clarke, B., Illari, P., Kelly, M. P., Norrell, C., Russo, F., Shaw, B., & Williamson, J. (2018). Evaluating evidence of mechanism in medicine: Principles and procedures. Springer.
  • Park, A., Steel, D., & Maine, E. (2023). Evidence-based medicine and mechanistic evidence: The case of the failed rollout of Efavirenz in Zimbabwe. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 48(4), 348–358. https://doi.org/10.1093/jmp/jhad019
  • Rocca, E. (2018). The judgments that evidence-based medicine adopts. Journal of Evaluation in Clinical Practice, 24(5), 1184–1190. https://doi.org/10.1111/jep.12994
  • Shan, T., & Williamson, J. (2023). Evidential pluralism in the social sciences. Routledge.
  • Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., Lloyd-Smith, J. O., de Wit, E., & Munster, V. J. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564–1567. https://doi.org/10.1056/NEJMc2004973
  • Verde, E. (2020). A bias-corrected meta-analysis model for combining, studies of different types and quality. Biometrical Journal, 63(2), 406–422. https://doi.org/10.1002/bimj.201900376
  • Weijer, C., Grimshaw, J. M., Eccles, M. P., McRae, A. D., White, A., & Brehaut, J. C. (2012). The Ottawa statement on the ethical design and conduct of cluster randomized trials. PLoS Medicine, 9(11), e1001346. https://doi.org/10.1371/journal.pmed.1001346
  • Williamson, J. (2019a). Establishing causal claims in medicine. International Studies in the Philosophy of Science, 32(1), 33–61. https://doi.org/10.1080/02698595.2019.1630927
  • Williamson, J. (2019b). Evidential proximity, independence, and the evaluation of carcinogenicity. Journal of Evaluation in Clinical Practice, 25(6), 955–961. https://doi.org/10.1111/jep.13226
  • World Health Organisation. (2019). Design of vaccine efficacy trials to be used during public health emergencies. https://www.who.int/docs/default-source/blue-print/working-group-for-vaccine-evaluation-(4th-consultation)/ap1-guidelines-online-consultation.pdf